Zusammenfassung
Innerhalb der letzten 15 Jahre konnten auf dem Gebiet der Forschung, Entwicklung, des klinischen Einsatzes und der Überwachung von Muskelrelaxantien beachtliche Fortschritte erzielt und damit ein weiterer Beitrag zur Erhöhung der intra- und postoperativen Sicherheit der Patienten geschaffen werden. Diese Entwicklung begann, nachdem sich in den 8oer Jahren die neuen, mittellang wirkenden Nichtdepolarisationsblocker Vecuronium und Atracurium, aber auch das langwirkende Pipecuronium fest im klinischen Alltag etablieren konnten und erreichte durch die klinische Einführung der Benzylisoquinolindiester Mivacurium und Cisatracurium und des Steroidrelaxans Rocuronium einen vorläufigen Höhepunkt.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Abouleish E, Abboud T, Lechevalier T, Zhu J, Chalian A, Alford K (1994) Rocuronium (Org 9426) for Caesarean section. Br J Anaesth 73: 336–341.
Agoston S (1995) Onset time and evaluation of intubating conditions: Rocuronium in perspective. Eur J Anaesthesiol; 12: 31–37.
Bartkowski RR, Witkowski TA, Azad S, Lessin J, Marr A (1993) Rocuronium onset of action: a comparison with atracurium and vecuronium. Anesth Analg 77: 574–578.
Booij LH, Knape HT (1991) The neuromuscular blocking effect of ORG 9426. A new intermediately-acting steroidal non-depolarizing relaxant in man. Anaesthesia 46: 341–343.
Bowman WC, Rodger IW, Houston J, Marshall RJ, Mclndewar I. Structure (1988) Action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anaesthetized cat. Anesthesiology 69: 57–62.
Brandom BW, Sarner JB, Woelfel SK, Dong ML, Horn MC, Borland LM, Cook DR, Foster VJ, BF McNulty, Weakly JN (1990) Mivacurium infusion requirements in pediatric surgical patients during nitrous oxide-halothane and during nitrous oxide-narcotic anesthesia. Anesth Analg 71: 16–22.
Cook DR (1993) Mivacurium in infants and children. J Drug Dev 5: (Suppl 1) 7–14.
Cook DR, Freeman JA, Lai AA, Kang Y, Stiller RL, Aggarwal S, Harrelson JC, Welch RM, Samara B (1992) Pharmacokinetics of mivacurium in normal patients and in those with hepatic or renal failure. Br J Anaesth 69: 580–585.
Cooper RA, Mirakhur RK, Clarke RS, Boules Z (1992) Comparison of intubating conditions after administration of ORG 9246 (rocuronium) and suxamethonium. Br J Anaesth 70: 269–273.
Deriaz H, Schmautz E, Vrilon M, Flienhart A (1994) Pharmacodynamics of repeated doses of 51W89 during surgery. Anesthesiology 81: A1092.
Engbaek J, Ostergaard D, Viby-Mogensen J (1989) Double burst stimulation ( DBS) A new pattern of nerve stimulation to identify residual neuromuscular block. Br J Anaesth 62: 274–278.
Foldes FF, Nagashima H, Nguyen HD, Schiller WS, Mason MM, Ohta Y (1991) The neuromuscular effects of ORG9426 in patients receiving balanced anesthesia. Anesthesiology 75: 191–196.
Frampton JE, McTavish D (1993) Mivacurium. A review of its pharmacology and therpeutic potential in general anaesthesia. Drugs 45: 1066–1089.
Goudsouzian NG, Alifimoff JK, Eberly C, Smeets R, Griswold J, Miler V, McNulty BF, Savarese J J (1989) Neuromuscular and cardiovascular effects of mivacurium in children. Anesthesiology. 70: 237–242.
Hofmockel R, Benad G, Jantschulev S (1995) Vergleich der neuromuskulären Blockade von Mivacurium und Atracurium. Anaesthesiol Reanim 20: 4–11
Hofmockel R, Benad G, Kabott A (1994) Mechanomyographische und elektromyographische Untersuchungen zur endotrachealen Intubation mit zwei verschiedenen Rocuronium-Dosierungen. Anaesthesiol Reanim 19: 144–148.
Huizanga AC, Vandenbrom RH, Wierda JM, Hommes FD, Hennis PJ (1992) Intubating conditions and onset of neuromuscular block of rocuronium (ORG 9426); a comparison with suxamethonium. Acta Anaesthesiol. Scand. 36: 463–468.
Hunter JM, De Wolf A (1996) The pharmacodynamics and pharmacokinetics of cisatracurium in patients with renal or hepatic failure. Curr Opin Anaesthesiol 9: 42–46.
Jones RM (1995) Mivacurium in special patient groups. Acta Anaesthesiol Scand 39: 47 - 54.
Kaiser E, Petit D, Quinot JF, Suppini A, Sallaberry M (1995) Curarisation prolongee apres mivacurium par deficit en pseudocholinesterases plasmatiques. Ann Fr Anesth Reanim 14: 505–507
Konstadt SN, Reich DL, Stanley TE, DePerio M, Chuey C, Schwartzbach C, Abou-Donia M (1995) A two-center comparison of the cardiovascular effects of cisatracurium ( NIMBEX) and vecuronium in patients with coronary artery disease. Anesth Analg; 81: 1010–1014.
Kopman AF (1989) Pancuronium, gallamine and d-Tubocurarine compared: Is speed of onset inversely related to drug potency? Anesthesiology; 70: 915–920.
Lake CL (1993) American monitoring: Standards and state of the art. Infusther Transfusionsmed 20: 104–110.
Lambalk LM, De-Wit AP, Wierda JM, Hennis PJ, Agoston S (1991) Dose response relationship and time course of action of ORG 9426. A new muscle relaxant of intermediate duration evaluated under various anaesthetic techniques. Anaesthesia; 46: 907–911.
Lapeyre G, Dubois M, Lea D, Kataria E, Tran D (1990) Effects of 3 intubating doses of ORG 9426 in humans. Anesthesiology 73: 34–36
Lien CA (1993) What is really new about the new relaxants? Anesthesiol Clin North Am 11: 729–778.
Littlejohn IH, Abhay K, El Sayad A, Broomhead CJ, Duvaldestin P, Flynn PJ (1995) Intubating conditions following 1R eis, l’R eis atracurium (51W89). Anaesthesia 50: 499–502.
Meretoja OA, Taivainen T (1995) Pharmacodynamic effects of 51W89, an isomer of atracurium, in children during halothane anaesthesia. Br J Anaesth 74: 6–11.
Meretoja OA; Taivainen T; Erkola O; Rautoma P; Juvakoski M (1995) Dose-response and time-course of effect of rocuronium bromide in paediatric patients. Eur J Anaesthesiol 12: 19–22.
Mogorian T, Flannery KB, Miller RD (1993) Comparison of rocuronium, succinylcholine, and vecuronium for rapid sequence induction of anaesthesia in adult patients. Anesthesiology 79: 913–918.
Muchhai KK, Viby-Mogensen J, Fernando PUE (1987) Evaluation of intense neuromuscular blockade caused by vecuronium using posttetanic count ( PTC ). Anesthesiology. 66: 846–849.
Ostergaard D, Jensen FS, Jensen E, Skovgaard LT, Viby-Mogensen J (1993) Mivacurium-induced neuromuscular blockade in patients with atypical plasma Cholinesterase. Acta Anaesthesiol Scand 37: 314–318.
Pavlin EG, Duvaldestin P, Belmont MR, Flynn PJ (1996) The use of cisatracurium for tracheal intubation. Curr Opin Anaesthesiol 9: 23–26
Puhringer FK, Khuenl-Brady, KS, Koller J, Mitterschiffthaler G (1992) Evaluation of the endotracheal intubation conditions of rocuronium (ORG 9426) and succinylcholine in outpatient surgery. Anesth. Analg. 76: 37–40.
Robertson EN, Hull JM, Verbeek AM, Booij LHD (1994) A comparison of rocuronium and vecuronium: The pharmacodynamic, cardiovascular and intra-ocular effects. Eur J Anaesthesiol 11: 116–121.
Savarese JJ (1993) Mivacurium: A comparison with other benzylisoquinolinium non-depolarising muscle relaxants. J Drug Dev 5: 1–5.
Savarese JJ, HH Ali, SJ Basta, PB Embree, RPF Scott, N Sunder, JN Weakly, WB Wastila, HA El-Sayad (1988) The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U) Anesthesiology 68: 723–732.
Scheiber G; Ribeiro FC; Marichal A; Bredendiek M; Renzing K (1996) Intubating conditions and onset of action after rocuronium, vecuronium, and atracurium in young children. Anesth Analg 83 320–324.
Schmith VD; Phillips L; Kisor DF; Fiedler Kelly J; Weatherley BC (1996) Pharmacokinetics/pharmacodynamics of cisatracurium in healthy adult patients. Curr Opin Anaesthesiol 9: 9–15
Viby Morgensen J, Engbaek J, Eriksson LI, Gramstad L, Jensen E, Jensen FS;, Koscielniak Nielsen Z, Skovgaard LT, Ostergaard D (1996) Good clinical research practice ( GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 40: 59–74.
Viby-Mogensen J, JensenE, WernerM, Kirkegaard-NielsenH (1988) Measurement of acceleration: A new method of monitoring neuromuscular function. Acta Anaesthesiol Scand 32: 45-48.
Wastila WB, Maehr RB, LaMunion GL, Belmont MR, Savarese JJ (1996) Preclinical pharmacology of cisatracurium besylate. Curr Opin Anaesthesiol 9: 2–8.
Wierda-JMKH; Proost-JH (1995) The pharmacokinetics and the pharmacokinetic-dynamic relationship of rocuronium bromide. Anaesth Pharmacol Rev. 3: 192–201.
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Hofmockel, R., Benad, G. (1996). Muskelrelaxantien 1997 — Ein Update. In: Refresher Course Aktuelles Wissen für Anästhesisten. Refresher Course Aktuelles Wissen für Anästhesisten, vol 23. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80367-3_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-80367-3_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-62552-0
Online ISBN: 978-3-642-80367-3
eBook Packages: Springer Book Archive